Invention Grant
- Patent Title: Microbiome markers and therapies for autism spectrum disorders
-
Application No.: US18147224Application Date: 2022-12-28
-
Publication No.: US12084727B2Publication Date: 2024-09-10
- Inventor: Rosa Krajmalnik-Brown , Dae-Wook Kang , Jin Gyoon Park , Joshua Labaer , Zehra IIhan
- Applicant: Arizona Board of Regents on Behalf of Arizona State University
- Applicant Address: US AZ Tempe
- Assignee: Arizona Board of Regents on Behalf of Arizona State University
- Current Assignee: Arizona Board of Regents on Behalf of Arizona State University
- Current Assignee Address: US AZ Tempe
- Agency: POLSINELLI PC
- The original application number of the division: US14403425
- Main IPC: C12Q1/689
- IPC: C12Q1/689 ; A61K31/437 ; A61K35/741 ; C12Q1/6883 ; G01N33/68

Abstract:
The present disclosure provides for characterization of normal flora and identifying biomarkers in the gut of healthy, neurotypical subjects. Aspect of the disclosure provide for the characterization of the gut microbiome in ADS subjects, characterized by reduced richness and significant loss of the ‘Prevotella-like enterotype’ compared to neurotypical subjects. The relative abundance of genera Prevotella, Coprococcus, Prevotellaceae and Veillonellaceae are significantly lower in autistic children than in neurotypical children. Further, Prevotella, is one of the three main classifiers for the human enterotypes, along with Bacteroides and Ruminococcus. These three core genera are among main contributors in the principle component analysis. ‘Prevotella-like enterotype’ was absent in the autistic group, while neurotypical samples showed an even distribution among the three enterotypes. The present disclosure provides for an understanding the association between gut microbiota, health, and disease states, and provides for potential diagnostic and therapeutic targets.
Public/Granted literature
- US20230220494A1 MICROBIOME MARKERS AND THERAPIES FOR AUTISM SPECTRUM DISORDERS Public/Granted day:2023-07-13
Information query
IPC分类: